Sean Brynjelsen Eton Pharmaceuticals, Inc. (ETON) insider trading activity

ETON Quotes by TradingView

Sean Brynjelsen is President & CEO of Eton Pharmaceuticals, Inc.. Currently has a direct ownership of 2.87 Million shares of ETON, which is worth approximately $44.9 Million. The most recent transaction as insider was on Jun 05, 2025, when has been sold 70,000 shares (Common Stock) at a price of $16.81 per share, resulting in proceeds of $1,176,700. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 2.87M
176.3% 3M change
176.3% 12M change
Total Value Held $44.9 Million

SEAN BRYNJELSEN Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 05 2025
SELL
Open market or private sale
$1,176,700 $16.81 p/Share
70,000 Reduced 2.38%
2,873,513 Common Stock
Jun 04 2025
SELL
Open market or private sale
$1,190,000 $17.0 p/Share
70,000 Reduced 2.32%
2,943,513 Common Stock
Jun 03 2025
SELL
Open market or private sale
$1,278,200 $18.26 p/Share
70,000 Reduced 2.27%
3,013,513 Common Stock
Sep 22 2022
BUY
Open market or private purchase
$21,000 $2.1 p/Share
10,000 Added 0.95%
1,040,000 Common Stock
Aug 20 2021
BUY
Open market or private purchase
$43,200 $4.32 p/Share
10,000 Added 0.96%
1,030,000 Common Stock
Jun 03 2021
BUY
Open market or private purchase
$29,800 $5.96 p/Share
5,000 Added 0.48%
1,030,000 Common Stock
SB

Sean Brynjelsen

President & CEO
Deer Park, IL

Track Institutional and Insider Activities on ETON

Follow Eton Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ETON shares.

Notify only if

Insider Trading

Get notified when an Eton Pharmaceuticals, Inc. insider buys or sells ETON shares.

Notify only if

News

Receive news related to Eton Pharmaceuticals, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ETON